Showing 4,141 - 4,160 results of 16,602 for search '(( 50 ms decrease ) OR ( 50 ((((we decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 0.53s Refine Results
  1. 4141
  2. 4142
  3. 4143
  4. 4144
  5. 4145

    COVID19 effect on essential services. by Admas Abera (11821659)

    Published 2024
    “…The present study found that the mean number of patients treated for TB declined by 35 patients (β: -34.62; 95%CI: -50.29, -18.95) compared to the pre-COVID-19 era while the number of new patients enrolled for ART decreased by 71 patients (β: -70.62; 95%CI: -107.19, -34.05). …”
  6. 4146

    Description of the cohort (N = 118 patients). by Bastien Le Floc’h (14773916)

    Published 2023
    “…We conducted a large prospective study that included 118 patients on HLA-G plasma levels during a 12-month follow-up and compared them to the status of anti-HLA antibodies. …”
  7. 4147

    Changing landscape configuration demands ecological planning: Retrospect and prospect for megaherbivores of North Bengal by Tanoy Mukherjee (6577076)

    Published 2019
    “…The present study also involves evaluation of landscape and anthropogenic predictors influence on the megaherbivores of GNP, followed by future landcover simulation for the year 2028. The result shows a significant decrease in the grassland cover from 18.87 km<sup>2</sup> to 8.27 km<sup>2</sup> from 1998 to 2018, whereas the woodland cover has increased from 50.14 km<sup>2</sup> to 62.09 km<sup>2</sup> between 1998 and 2018. …”
  8. 4148
  9. 4149
  10. 4150
  11. 4151
  12. 4152
  13. 4153

    Data_Sheet_1_HMG-Coenzyme A Reductase as a Drug Target for the Prevention of Ankylosing Spondylitis.docx by Zhenyu Zhong (6861935)

    Published 2021
    “…No significant association with ankylosing spondylitis was observed for the PCSK9 score (OR, 0.89; 95% CI, 0.68–1.16) and the NPC1L1 score (OR, 1.50; 95% CI, 0.39–5.77). For the LDL score, genetically determined per mmol/L decrease in LDL cholesterol levels led to a reduced risk of ankylosing spondylitis (OR, 0.64; 95% CI, 0.43–0.94), with significant heterogeneity and pleiotropy in the estimate. …”
  14. 4154
  15. 4155
  16. 4156

    Supplementary materials. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
  17. 4157
  18. 4158

    Selective Inhibitors of Janus Kinase 3 Modify Responses to Lipopolysaccharides by Increasing the Interleukin-10-to-Tumor Necrosis Factor α Ratio by Julian Laux (13047767)

    Published 2023
    “…., tofacitinib, 0.2–0.4 μmol/kg bid) in clinical use, suggesting an efficient underlying mode of action. We hypothesized that their effectiveness is due to their ability to raise the ratio of IL-10 to TNFα. …”
  19. 4159

    Summary of subgroup analysis results. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”
  20. 4160

    PRISMA Flow Chart 2020. by Yongki Welliam (21030005)

    Published 2025
    “…Meta-analysis revealed that increasing OPN (SMD = 5.52, 95% CI = 1.59–9.44, p = 0.01) and KIM-1 (SMD = 1.45, 95% CI = 0.50–2.39, p = 0.0027), as well as decreasing Fetuin-A level (SMD = -1.31, 95% CI = -2.37 – -0.26, p = 0.01) were significant in CKD patients with ESRD. …”